Reversal of Signs and Symptoms of a B-Cell Lymphoma in a Patient Using Only Low-Dose Naltrexone

Abstract

References

Berkson BM , Rubin DM , Berkson AJ The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol. Integr Cancer Ther. 2006 ;5(1):83-89.

Freedman AS , Harris NL Clinical and pathologic features of follicular lymphoma. www.uptodate.com. Accessed June 5, 2007.

Hennessy BT , Hanrahan EO , Daly PA Non-Hodgkin lymphoma: an update. Lancet Oncol. 2004;5:341-353.

Ott OJ , Rodel C. , Gramatzki M. , et al. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma . Strahlenther Onkol. 2003;179:694-701.

van Oers MH , Klasa R. , Marcus RE , et al. Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial . Blood. 2006;108(10):3295-3301.

Jankovic BD , Radulovic J. Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity. Int J Neurosci. 1992;67(1-4): 241-270.

Bihari B.

Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV/AIDS [letter]. AIDS

Patient Care. 1995 ;9(1):3.rt

Smith JP , Stock H. , Bingaman S. , Mauger D. , Rogosnitzky M. , Zagon IS Low-dose naltrexone improves active Crohn's disease. Am J Gastroenterol. 2007;102(4):820-828.

Bihari B. LDN and cancer. Low Dose Naltrexone Web site. http://www.lowdosenaltrexone.org . Accessed June 5, 2007.

10.

Mathews PM , Froelich CJ , Sibbitt WL , Bankhurst AD Enhancement of natural cytotoxicity by beta-endorphin. J Immunol. 1983;130(4):1658-1662.

11.

Singleton PA , Lingen MW , Fekete MJ , Garcia JG , Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res. 006;72 (1-2):3-11. http://www.clinicalpharmacology.com/apps/default.asp?entry=11&rNum=430.

12.

Zagon IS , McLaughln PJ Naltrexone modulates tumor response in mice with neuroblastoma. Science. 1983;221:671-673.

13.

Zagon IS , McLaughlin PJ Opioids and the apoptotic pathway in human cancer cells. Neuropeptides. 2003;37:79-88.

14.

Lissoni P. , Meregalli S. , Fossati V. , et al. Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapy. Tumori. 1993;79: 198-201.